Ra: Part 2 Post-test

6 Questions | Total Attempts: 31

SettingsSettingsSettings
MCQ Quizzes & Trivia

1. Enter your name, including first name, last name plus credentials2. Password: pafp13. Click "start quiz" 4. Answer the 6 multiple choice questions to receive a test score and a link to your CME certificate. PAFP members, be sure to provide your name so that we assign your reward point!


Questions and Answers
  • 1. 
    What has been the least successful target for biologic therapy in RA:
    • A. 

      IL-6

    • B. 

      IL-1

    • C. 

      TNF

    • D. 

      B cells

  • 2. 
    Monitoring for Methotrexate hepatotoxicity should be done:
    • A. 

      Monthly for the duration of therapy

    • B. 

      Monthly during dose titration then every 6 months

    • C. 

      Monthly during dose titration then every 2 months

    • D. 

      Monthly during dose titration then every 3 months

  • 3. 
    Which of these is currently felt to be the best predictor of long term disability:
    • A. 

      Erosions

    • B. 

      Degree of synovitis

    • C. 

      CRP level

    • D. 

      Rheumatoid factor status

  • 4. 
    A patient with RA on a TNF inhibitor returns from visiting family in India  develops cough and fever which of these needs to be excluded:
    • A. 

      Coccidiomycosis

    • B. 

      Blastomycosis

    • C. 

      Tuberculosis

    • D. 

      Histoplasmosis

  • 5. 
    The rational for early aggressive therapy of RA rests on the finding that:
    • A. 

      It is more effective in reducing joint pain

    • B. 

      It prevents extra articular disease

    • C. 

      It improves longevity

    • D. 

      It reduces the radiologic progression of the disease

  • 6. 
    Which of these should be done in all patients receiving TNF therapy:
    • A. 

      PPD

    • B. 

      Hepatitis C screening

    • C. 

      Cancer screening

    • D. 

      Nasal swap for staph carrier state

Back to Top Back to top